Position in VTRS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$40,084
+$3,071 QoQ
Shares Held
2,967
-0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GW&K Investment Management, LLC holds $163,730,959 across 8 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
593,725 | $78,217,331 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,055,184 | $54,542,460 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
3,240,462 | $30,849,197 | |
| 4 | VTRS |
Viatris Inc
This page
|
2,967 | $40,084 | |
| 5 | HLN |
Haleon plc
|
3,869 | $38,728 | |
| 6 | ZTS |
Zoetis Inc.
|
208 | $24,587 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
580 | $10,741 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
260 | $7,831 |
All Filings in VTRS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,084 | 2,967 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $37,013 | 2,973 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $29,432 | 2,973 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $27,066 | 3,031 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $6,323 | 726 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $10,769 | 865 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $9,241 | 796 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $8,663 | 815 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,098 | 762 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $8,035 | 742 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,517 | 661 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,618 | 563 | Shares | Sole | 2023-08-09 | |
| 2022-06-30 | $3,235 | 309 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,057 | 281 | Shares | Sole | 2022-05-09 | |
| No filing history on record for this holder in this stock. | ||||||